Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners

PLoS One. 2015 Mar 26;10(3):e0121371. doi: 10.1371/journal.pone.0121371. eCollection 2015.

Abstract

CpG-ODNs activate dendritic cells (DCs) to produce interferon alpha (IFNα) and beta (IFNβ). Previous studies demonstrated that Toll-like receptor 9 (TLR9) deficient DCs exhibited a residual IFNα response to CpG-A, indicating that yet-unidentified molecules are also involved in induction of IFNα by CpG-A. Here, we report that the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) but not Ku70 deficient BMDCs showed defective IFNα and IFNβ responses to CpG-A or CpG-B. Loss of both DNA-PKcs and TLR9 further reduced the IFNα response to CpG-A. These DNA-PKcs and TLR9 effects were mediated by their downstream Akt/mTORC1 pathway and downstream events IRAK1 and IKKα. Loss of DNA-PKcs, TLR9, MyD88 or IRAK4 impaired phosphorylation of Akt(S473), S6K, S6, IRAK1, or IKKα in BMDCs in response to CpG-ODNs. The residual IFNα and IFNβ in DNA-PKcs-deficient BMDCs were partially responsible for the induction of IL-6 and IL-12 by CpG-ODNs and their stimulatory effect was blocked by IFNAR1 neutralizing antibodies. Further analysis indicated that CpG-ODN associated with DNA-PKcs and Ku70, and induced DNA-PKcs's interaction with TRAF3. Intriguingly, DNA-PKcs but not Ku70 expression level was reduced in TLR9-deficient BMDCs. Taken together, our data suggest that DNA-PKcs is an important mediator in the type I IFN response to CpG-ODNs in TLR9-dependent or -independent fashions.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antigens, Nuclear / immunology
  • Antigens, Nuclear / metabolism
  • DNA-Activated Protein Kinase / genetics
  • DNA-Activated Protein Kinase / metabolism*
  • DNA-Binding Proteins / immunology
  • DNA-Binding Proteins / metabolism
  • Dendritic Cells / drug effects*
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism*
  • Interferon Type I / pharmacology*
  • Interleukin-1 Receptor-Associated Kinases / metabolism
  • Interleukin-12 / metabolism
  • Interleukin-12 / pharmacology
  • Interleukin-6 / metabolism
  • Interleukin-6 / pharmacology
  • Ku Autoantigen
  • Mechanistic Target of Rapamycin Complex 1
  • Mice
  • Mice, Knockout
  • Multiprotein Complexes / metabolism
  • Myeloid Differentiation Factor 88 / metabolism
  • Oligodeoxyribonucleotides / pharmacology*
  • Phosphorylation
  • Protein Binding
  • Proto-Oncogene Proteins c-akt / metabolism
  • STAT1 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • TNF Receptor-Associated Factor 3 / metabolism
  • TOR Serine-Threonine Kinases / metabolism
  • Toll-Like Receptor 9 / genetics
  • Toll-Like Receptor 9 / metabolism*

Substances

  • Antigens, Nuclear
  • CPG-oligonucleotide
  • DNA-Binding Proteins
  • Interferon Type I
  • Interleukin-6
  • Multiprotein Complexes
  • Myeloid Differentiation Factor 88
  • Oligodeoxyribonucleotides
  • STAT1 Transcription Factor
  • TNF Receptor-Associated Factor 3
  • Toll-Like Receptor 9
  • Interleukin-12
  • DNA-Activated Protein Kinase
  • Interleukin-1 Receptor-Associated Kinases
  • Mechanistic Target of Rapamycin Complex 1
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Xrcc6 protein, mouse
  • Ku Autoantigen